Invention Grant
- Patent Title: Agent for improving mitochondrial function
-
Application No.: US17279941Application Date: 2019-09-26
-
Publication No.: US12083152B2Publication Date: 2024-09-10
- Inventor: Takashi Ito , Mitsutoshi Setou , Satoru Ozaki , Chinami Mizoguchi , Yukio Asami
- Applicant: MEIJI CO., LTD. , NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE
- Applicant Address: JP Tokyo
- Assignee: MEIJI CO., LTD.,NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE
- Current Assignee: MEIJI CO., LTD.,NATIONAL UNIVERSITY CORPORATION HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE
- Current Assignee Address: JP Tokyo; JP Shizuoka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP 18180969 2018.09.26
- International Application: PCT/JP2019/038014 2019.09.26
- International Announcement: WO2020/067368A 2020.04.02
- Date entered country: 2021-09-20
- Main IPC: A61K35/747
- IPC: A61K35/747 ; A23L33/135
Abstract:
The present invention provides a mitochondrial function-improving agent containing a lactic acid bacterium belonging to Lactobacillus farciminis or Pediococcus acidilactici, a culture of the lactic acid bacterium, or a culture supernatant of the lactic acid bacterium.
Public/Granted literature
- US20220008489A1 AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION Public/Granted day:2022-01-13
Information query
IPC分类:
